Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia. [electronic resource]
Producer: 20191002Description: 1308-1316 p. digitalISSN:- 1592-8721
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Benzylamines
- Cell Movement
- Cyclams
- Decitabine -- therapeutic use
- Female
- Heterocyclic Compounds -- therapeutic use
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Receptors, CXCR4 -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.